PYXS · ISSUER CIK 1782223
Pyxis Oncology, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Pyxis Oncology, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Oct 2, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 202608:35 | Oct 1, 2026 | PYXS | 10% Owner · +3 joint | P · Buy | — | +5,517,000 | 15,541,909 | +55% | — | — | — |